Every Spin-Off
Apollo Healthtech (Apollo HealthCo)
AnnouncedINRuns Apollo's pharmacy distribution and its Apollo 24|7 online pharmacy and telehealth app in India, combined with drug wholesaler Keimed.
Apollo Hospitals' omnichannel pharmacy distribution, Apollo 24|7 digital platform and telehealth businesses (Apollo HealthCo), to be combined with Keimed; projected FY25 revenue of about Rs 16,300 crore, with a Rs 25,000 crore run-rate targeted.
- Status
- Announced
- Expected
- Q1 2027
- Parent
- Apollo Hospitals Enterprise (APOLLOHOSP IN)
- Spin-off ticker
- To be announced
- Listing
- NSE and BSE
- Market
- India
- Sector
- Health care
Terms
Apollo Hospitals shareholders receive 195.2 Apollo Healthtech shares for every 100 shares held; Keimed merges into the new company; CCI cleared Sep 2025; NCLT-convened shareholder meeting 24 Jun 2026; SEBI and NCLT sanction pending; listing on NSE and BSE targeted for Q4 FY27 (Jan-Mar 2027).
Key dates
- Board approval
- CCI clearance
- NCLT order convening meetings
- Shareholder meeting
- NCLT sanction and listing
Source documents
- Press releaseSource: business-standard.com (plan and ratio, 07/01/25)
- PresentationNot yet published
- Prospectus / demerger documentNot yet public
- Sourcebasispointinsight.com (CCI clearance)
- Sourcemultibagg.ai (listing timeline)
Every Spin-Off research
No report on this situation yet. New reports are published on Substack first.
Receive reports by email